Randall G. Brockman

Learn More
A trial fibrillation (AF) poses a major global public health challenge because it is increasing in prevalence and is associated with an increased risk of stroke, dementia, heart failure, and death. 1–3 In response to the many challenges posed by AF, the American Heart Association (AHA) con-(Appendix). The 22 presentations and 6 panel discussions were(More)
  • 1